Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

8.7K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.7K
Insulin: Biosynthesis, Chemistry, and Preparation01:25

Insulin: Biosynthesis, Chemistry, and Preparation

514
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
514
Drug Biotransformation: Overview01:28

Drug Biotransformation: Overview

1.3K
Biotransformation, also known as drug metabolism, is a vital physiological process that chemically alters drugs, facilitating their elimination from the body and terminating their action. This process involves two main phases: phase I and phase II reactions. Phase I reactions, including oxidation, reduction, and hydrolysis, introduce or unmask polar functional groups on the drug molecule, thereby increasing its water solubility. By enhancing water solubility, the drug becomes more hydrophilic...
1.3K
Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

286
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
286
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

414
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
414
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

7.3K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
7.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Azide-Alkene Cycloaddition and Visible-Light-Mediated Wolff Rearrangement of Sugar Enones.

The Journal of organic chemistry·2026
Same author

Reply to the "Comment on 'Intramolecular Proton-Coupled Hydride Transfers with Relatively Low Activation Barriers'".

The journal of physical chemistry. A·2025
Same author

Halogenated butyrolactones from the biomass-derived synthon levoglucosenone.

Beilstein journal of organic chemistry·2025
Same author

Acid-Catalyzed Redox Isomerizations of 6,8-Dioxabicyclo[3.2.1]octan-4-ols Provide Mechanistic Insights for Levoglucosenone Formation.

ChemSusChem·2024
Same author

Skeletal rearrangement of 6,8-dioxabicyclo[3.2.1]octan-4-ols promoted by thionyl chloride or Appel conditions.

Beilstein journal of organic chemistry·2024
Same author

Practical and scalable enantioselective synthesis of (+)-majoranolide from Cyrene.

Organic & biomolecular chemistry·2024

Related Experiment Video

Updated: Sep 7, 2025

GENPLAT: an Automated Platform for Biomass Enzyme Discovery and Cocktail Optimization
11:38

GENPLAT: an Automated Platform for Biomass Enzyme Discovery and Cocktail Optimization

Published on: October 24, 2011

15.5K

Levoglucosenone: Bio-Based Platform for Drug Discovery.

Jason E Camp1, Ben W Greatrex2

  • 1Circa Sustainable Chemicals, York, United Kingdom.

Frontiers in Chemistry
|June 17, 2022
PubMed
Summary

Levoglucosone (LGO), a versatile molecule from waste biomass, is a key building block for synthesizing complex compounds. Its derivatives show potential in developing new anti-cancer, anti-microbial, and anti-inflammatory drugs.

Keywords:
bio-masschiral building blockdrug discoverylevoglucosenoneplatform chemical

More Related Videos

A Platform of Anti-biofilm Assays Suited to the Exploration of Natural Compound Libraries
09:39

A Platform of Anti-biofilm Assays Suited to the Exploration of Natural Compound Libraries

Published on: December 27, 2016

17.9K
A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform
09:35

A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform

Published on: July 16, 2016

11.3K

Related Experiment Videos

Last Updated: Sep 7, 2025

GENPLAT: an Automated Platform for Biomass Enzyme Discovery and Cocktail Optimization
11:38

GENPLAT: an Automated Platform for Biomass Enzyme Discovery and Cocktail Optimization

Published on: October 24, 2011

15.5K
A Platform of Anti-biofilm Assays Suited to the Exploration of Natural Compound Libraries
09:39

A Platform of Anti-biofilm Assays Suited to the Exploration of Natural Compound Libraries

Published on: December 27, 2016

17.9K
A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform
09:35

A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform

Published on: July 16, 2016

11.3K

Area of Science:

  • Organic Chemistry
  • Biomass Valorization
  • Medicinal Chemistry

Background:

  • Levoglucosone (LGO) is a bio-privileged chiral building block.
  • LGO can be produced economically from waste biomass.
  • It serves as a versatile starting material for synthesizing valuable chemical entities.

Purpose of the Study:

  • To review the chemical transformations of LGO into diverse building blocks.
  • To highlight the synthesis of biologically active compounds from LGO.
  • To outline future research directions for LGO as a platform molecule.

Main Methods:

  • Established chemical processes for LGO conversion.
  • Synthesis of enantiopure butenolides, dihydropyrans, cyclopropanes, deoxy-sugars, and ribonolactones.
  • Exploration of LGO derivatives for biological activity.

Main Results:

  • Demonstrated conversion of LGO into previously inaccessible chiral building blocks.
  • Identified LGO as a precursor for compounds with anti-cancer, anti-microbial, and anti-inflammatory potential.
  • Established LGO as a valuable platform molecule in synthetic chemistry.

Conclusions:

  • LGO is a highly adaptable and sustainable starting material.
  • Its derivatives hold significant promise for drug discovery and development.
  • Further research into LGO chemistry can unlock new therapeutic agents.